Pages that link to "Q46656681"
Jump to navigation
Jump to search
The following pages link to Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. (Q46656681):
Displaying 37 items.
- Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis (Q21089955) (← links)
- Recent advances of novel targeted therapy in non-small cell lung cancer (Q21092930) (← links)
- The retinoid X receptors and their ligands (Q24562747) (← links)
- Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses (Q24604495) (← links)
- Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites (Q27025972) (← links)
- Cotargeting Cyclin D1 Starts a New Chapter in Lung Cancer Prevention and Therapy (Q28239407) (← links)
- Advances in drug design with RXR modulators (Q28274388) (← links)
- Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis (Q30897591) (← links)
- Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma (Q33728138) (← links)
- AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors (Q34063390) (← links)
- The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration (Q35208501) (← links)
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer (Q35587470) (← links)
- Targeting truncated RXRα for cancer therapy (Q36398740) (← links)
- Retinoids and rexinoids in cancer prevention: from laboratory to clinic (Q36680198) (← links)
- Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment (Q36745391) (← links)
- Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation. (Q37082125) (← links)
- Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression (Q37126227) (← links)
- Clinical development of MVA-based therapeutic cancer vaccines (Q37259579) (← links)
- Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives (Q37601036) (← links)
- The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer (Q37603638) (← links)
- Implications of key trials in advanced nonsmall cell lung cancer (Q37678306) (← links)
- Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways (Q37681728) (← links)
- Recent Development of Molecular-Targeted Drugs in Lung Cancer (Q37789579) (← links)
- Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trials (Q37986608) (← links)
- Lung cancer chemoprevention: difficulties, promise and potential agents? (Q38061199) (← links)
- Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects? (Q38166454) (← links)
- The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target (Q38852028) (← links)
- Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine (Q44158911) (← links)
- Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells. (Q48275146) (← links)
- A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer (Q58771125) (← links)
- Targeted Therapy in Lung Cancer; Lessons Learned from Past Experiences (Q82062706) (← links)
- A Phase I Trial of Bexarotene in Combination With Docetaxel in Patients With Advanced Solid Tumors (Q84501425) (← links)
- Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities (Q90290673) (← links)
- Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer (Q90427395) (← links)
- Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis (Q92425757) (← links)
- The potential of retinoids for combination therapy of lung cancer: Updates and future directions (Q93121747) (← links)
- The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer (Q104495343) (← links)